
Friday, May 10, 2024 8:29:11 PM
All I want is Patience, and I want it NOW!!!!!!!!!
Recent IONI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2025 01:57:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/02/2025 01:13:06 PM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 04/15/2025 01:21:14 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/14/2025 10:56:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/14/2025 09:21:16 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2025 08:05:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 08:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2025 09:28:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2025 03:56:50 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/02/2024 09:58:11 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 11/18/2024 09:13:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2024 08:52:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 03:32:13 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/27/2024 02:40:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/19/2024 10:11:21 AM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 09/17/2024 08:31:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 10:10:35 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 05:43:42 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/12/2024 09:09:14 PM
Glidelogic Corp. Announces Release of First AI-Generated Novel "The Thirteenth Proposal" • GDLG • Jul 11, 2025 12:20 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM